Fast Five Quiz: Do You Know the Current Guidelines for the Screening and Treatment of Prostate Cancer?

Tan Winston, MD; Bradley Schwartz, DO


April 18, 2022

According to the AUA, the greatest benefit of screening appears to be for men 55-69 years of age. The decision to undergo PSA screening involves weighing the benefits of reducing the rate of metastatic prostate cancer and preventing prostate cancer death against the known potential harms associated with screening and treatment. For this reason, the AUA strongly recommends shared decision-making for patients of this age group along with their practitioner and proceeding on the basis of a man's values and preferences. In the interest of preserving the majority of benefits of screening and overdiagnosis and false positives, a routine screening interval of ≥ 2 years may be preferred over annual screening.

The AUA guidelines do not recommend testing in men ≤ 40 years of age, in men 40-54 years of age who are at average risk, in men ≥ 70 years of age, or in men with a life expectancy of < 10-15 years of age.

Learn more about the screening guidelines for prostate cancer.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.